Benzinga - Thu, 25 Feb 2021 17:49:26 -0400
Benzinga - Thu, 25 Feb 2021 05:03:36 -0400
Benzinga - Fri, 19 Feb 2021 08:02:08 -0400
Benzinga - Tue, 16 Feb 2021 05:54:34 -0400
Benzinga - Fri, 12 Feb 2021 13:59:44 -0400
load more
Sector: Health Care.Industry: Biotechnology
Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease. The company's product candidates include: CLBS119, for the repair of lung damage found in patients with severe COVID-19 infection who experienced respiratory failure, clinical trial to be initiated in 3Q2020 (USA); CLBS12, recipient of a SAKIGAKE (Japan) and ATMP (Europe) designations, eligible for early conditional approval for the treatment of critical limb ischemia based on an ongoing clinical trial (Japan); CLBS16, subject of the completed proof-of-concept ESCaPE-CMD clinical and planned Phase 2B (U.S.A.); and CLBS14, a Phase 3 ready clinical program in no option refractory disabling angina and recipient of a RMAT designation (USA).

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS-0.250-0.280 -0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CLBSCaladrius Biosciences-1.65%106.5M

Caladrius Biosciences Company Questions & Answers

Q

How do I buy Caladrius Biosciences (CLBS) stock?

A

You can purchase shares of Caladrius Biosciences (NASDAQ: CLBS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Caladrius Biosciences's (CLBS) main competitors?

A

Other companies in Caladrius Biosciences’s space includes: AEterna Zentaris (NASDAQ:AEZS), Cleveland BioLabs (NASDAQ:CBLI) and Celyad Oncology (NASDAQ:CYAD).

Q

What is the target price for Caladrius Biosciences?

A

The latest price target for Caladrius Biosciences (NASDAQ: CLBS) was reported by Brookline Capital on 2021-03-03. The analyst firm set a price target for 10.00 expecting CLBS to rise to within 12 months (a possible 458.66% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Caladrius Biosciences (CLBS) stock ?

A

The stock price for Caladrius Biosciences (NASDAQ: CLBS) is $1.79 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Caladrius Biosciences (CLBS) dividend?

A

There are no upcoming dividends for Caladrius Biosciences.

Q

When is Caladrius Biosciences (NASDAQ:CLBS) reporting earnings?

A
Caladrius Biosciences’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for CLBS?

A

There is no upcoming split for Caladrius Biosciences.